Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Hematology

Managing Triggers: Preventing Acute Attacks

At a Glance

Preventing porphyria attacks requires strict management of metabolic triggers. Patients must verify all medications using specialized databases, avoid fasting to maintain stable blood sugar, use iron oxide sunscreens to block visible light, and avoid alcohol to keep the disease dormant.

Living with porphyria means becoming a vigilant guardian of your body’s metabolic balance. Because your “assembly line” for heme is fragile, certain factors in your environment or lifestyle can push it into overdrive, causing a toxic buildup [1][2]. Managing these “triggers” is the most powerful tool you have to prevent acute attacks and skin flares.

The ALAS1 “Switch”

In Acute Hepatic Porphyria (AHP), attacks are driven by an enzyme called ALAS1. Think of ALAS1 as a switch that turns on the heme production line [3]. When this switch is pushed too hard by a trigger, it creates a flood of neurotoxic chemicals (ALA and PBG) that attack your nervous system [4][5].

1. Medication Safety: Your First Priority

Many common medications are potent triggers because they force your liver to make more heme, flipping the ALAS1 switch to “high” [6].

  • The Golden Rule: Never take a new medication—including over-the-counter drugs, herbal supplements, or vitamins—without checking it first.
  • The Resource: Use specialized databases like drugs-porphyria.org or the American Porphyria Foundation database. If a drug is listed as “unsafe” or “potentially porphyrinogenic,” it must be avoided [7].

2. Nutrition: The Power of Glucose

Your heme assembly line is sensitive to your energy levels. Low blood sugar (glucose) and fasting are major triggers for acute attacks [8][9].

  • Stable Fuel: Eat regular, balanced meals. Avoid “crash” diets, intermittent fasting, or extreme low-carbohydrate (Keto) diets.
  • Emergency Carbohydrates: If you feel the very early “twinge” of an attack, increasing your intake of complex carbohydrates or using glucose-rich drinks may help suppress the ALAS1 enzyme and potentially ward off a full flare [10][11].
  • Crucial Safety Caveat: If severe nausea or vomiting prevents you from keeping carbohydrates down, you are trapped in a dangerous fasting state that accelerates the attack. Do not delay—go to the ER immediately for intravenous (IV) glucose or hemin. Never rely solely on carbohydrates if symptoms rapidly progress or involve neurological changes like weakness [12].

3. Protecting Yourself in Emergencies

Because AHP attacks can cause severe confusion or “brain fog,” and because ER doctors may not know which standard anti-nausea or pain medications are safe, it is vital to be prepared:

  • Medical Alert Bracelet: Wear a medical alert ID so EMTs or ER staff are quickly alerted to your rare diagnosis.
  • Emergency Protocol: Always carry a printed “Safe Drugs” list and an emergency letter from your specialist. This prevents you from accidentally receiving contraindicated medications that could make the attack worse [7].

4. Hormones and the Cycle

For many women, the hormone progesterone is a primary trigger. This leads to “cyclical attacks” that occur in the week before a menstrual period [13]. Pregnancy also involves significant hormonal shifts that require close monitoring by a porphyria specialist [14].

Managing Cutaneous (Skin) Triggers

If you have a cutaneous type like EPP or PCT, your triggers are different but equally important.

  • Beyond UV Light: Standard sunscreens only block ultraviolet (UV) light. However, porphyria skin reactions are triggered by visible light (the light you can see) [15][16].
    • Protection: Visible light passes through glass, so you need protection even inside a car or near a window [17]. You can install special window tints that block visible light in your home or car (look for films designed specifically for sun-sensitive conditions).
    • Use physical barriers like wide-brimmed hats, gloves, and “tinted” sunscreens that contain iron oxides, which are specifically designed to block visible light wavelengths [16].
  • The PCT “Duo”: Alcohol and Iron: For those with Porphyria Cutanea Tarda (PCT), alcohol and excess iron in the liver are the most common triggers [18][19]. Avoiding alcohol and treating underlying iron overload can often lead to a complete disappearance of skin symptoms [20][21].

Other Key Triggers

  • Alcohol: Alcohol is a major inducer of the heme pathway and should be strictly avoided by most patients with AHP or PCT [20].
  • Infection and Stress: Both physical illness and significant emotional stress act as metabolic stressors that can flip the ALAS1 switch [14]. Treating infections early and practicing stress-reduction techniques are vital parts of your prevention plan.

Return to Home

Common questions in this guide

How can I check if a medication is safe for porphyria?
You should never take a new medication, over-the-counter drug, or supplement without verifying its safety first. Check specialized resources like drugs-porphyria.org or the American Porphyria Foundation database to ensure the drug will not trigger a flare.
Why do I need to eat regular meals if I have acute hepatic porphyria (AHP)?
Fasting and low blood sugar are major triggers for acute porphyria attacks. Eating regular, balanced meals and avoiding extreme low-carb or crash diets helps keep your metabolism stable and suppresses the enzyme that drives attacks.
What is the best sunscreen for cutaneous porphyria?
Standard sunscreens that only block UV light are not enough, because porphyria skin reactions are triggered by visible light. You need tinted sunscreens containing iron oxides to effectively block visible light wavelengths.
Why do my porphyria attacks happen right before my period?
For many women, the hormone progesterone acts as a major trigger for acute attacks. The hormonal shifts that naturally occur in the week before a menstrual period can overstimulate the heme pathway, leading to cyclical attacks.
Do I need to avoid alcohol if I have porphyria?
Yes, alcohol is a potent trigger that overstimulates the metabolic pathway involved in porphyria. It should be strictly avoided by most patients with acute hepatic porphyria (AHP) and porphyria cutanea tarda (PCT).

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we review my current medication list using a specialized porphyria database to ensure everything is safe?
  2. 2.Given my diagnosis, what is the best way for me to manage my weight or diet without triggering an attack?
  3. 3.If I experience early symptoms of an attack, should I increase my intake of complex carbohydrates or use a specific glucose supplement?
  4. 4.For my skin sensitivity, can you recommend a 'tinted' sunscreen that contains iron oxides to block visible light?
  5. 5.How should we handle potential triggers like upcoming surgeries or necessary medications that might be on the 'unsafe' list?
  6. 6.If my attacks seem related to my menstrual cycle, what hormonal management options are safe for me?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver.

    Schmitt C, Lenglet H, Yu A, et al.

    Journal of internal medicine 2018; (284(1)):78-91 doi:10.1111/joim.12750.

    PMID: 29498764
  2. 2

    The acute hepatic porphyrias.

    Wang B

    Translational gastroenterology and hepatology 2021; (6()):24 doi:10.21037/tgh-2020-01.

    PMID: 33824928
  3. 3

    Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.

    Wang B, Ventura P, Takase KI, et al.

    Orphanet journal of rare diseases 2022; (17(1)):327 doi:10.1186/s13023-022-02463-x.

    PMID: 36028858
  4. 4

    RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.

    Sardh E, Harper P

    Journal of internal medicine 2022; (291(5)):593-610 doi:10.1111/joim.13443.

    PMID: 35067977
  5. 5

    Pharmacokinetic-pharmacodynamic model of urinary δ-aminolevulinic acid reduction after givosiran treatment in patients with acute hepatic porphyria.

    Lee J, Melch M, Robbie GJ

    CPT: pharmacometrics & systems pharmacology 2023; (12(6)):842-852 doi:10.1002/psp4.12957.

    PMID: 36883675
  6. 6

    Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.

    Sachar M, Li F, Liu K, et al.

    Chemical research in toxicology 2016; (29(8)):1293-7 doi:10.1021/acs.chemrestox.6b00121.

    PMID: 27438535
  7. 7

    Guide for the classification of porphyrias using state-of-the-art reverse-phase high-performance liquid chromatography.

    Laguna J, Wijngaard R, Marés L, et al.

    Scandinavian journal of clinical and laboratory investigation 2025; (85(5)):327-339 doi:10.1080/00365513.2025.2524714.

    PMID: 40600928
  8. 8

    Acute intermittent porphyria (AIP) in a patient with celiac disease.

    Nunnemann S, Uibel C, Budig P, Mäurer M

    Neurological research and practice 2020; (2()):2 doi:10.1186/s42466-020-0049-6.

    PMID: 33324908
  9. 9

    Acute hepatic porphyrias: Recommendations for diagnosis and management with real-world examples.

    Moghe A, Dickey A, Erwin A, et al.

    Molecular genetics and metabolism 2023; (140(3)):107670 doi:10.1016/j.ymgme.2023.107670.

    PMID: 37542766
  10. 10

    Protocol For Patients With Suspected Acute Porphyria.

    Castelbón Fernández FJ, Solares Fernandez I, Arranz Canales E, et al.

    Revista clinica espanola 2020; (220(9)):592-596 doi:10.1016/j.rce.2019.10.012.

    PMID: 32143835
  11. 11

    Effect of Menstrual Cycle on Acute Intermittent Porphyria.

    Júnior VRS, Lemos VMV, Feitosa IML, et al.

    Child neurology open 2017; (4()):2329048X17736170 doi:10.1177/2329048X17736170.

    PMID: 29094055
  12. 12

    A novel HMBS gene mutation in acute intermittent porphyria: a case report of abdominal pain, seizures, and reversible neuroimaging findings.

    Dong W, Zeng B, Wang X, et al.

    Frontiers in genetics 2025; (16()):1551832 doi:10.3389/fgene.2025.1551832.

    PMID: 40110035
  13. 13

    Neurology of the acute hepatic porphyrias.

    Oliveira Santos M, Leal Rato M

    Journal of the neurological sciences 2021; (428()):117605 doi:10.1016/j.jns.2021.117605.

    PMID: 34375916
  14. 14

    International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyrias.

    Chen B, Whatley S, Badminton M, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(11)):2605-2613 doi:10.1038/s41436-019-0537-7.

    PMID: 31073229
  15. 15

    An overview of the cutaneous porphyrias.

    Dawe R

    F1000Research 2017; (6()):1906 doi:10.12688/f1000research.10101.1.

    PMID: 29152226
  16. 16

    Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria.

    Teramura T, Mizuno M, Asano H, et al.

    The Journal of dermatology 2018; (45(2)):145-149 doi:10.1111/1346-8138.14175.

    PMID: 29266358
  17. 17

    Congenital erythropoietic porphyria: Recent advances.

    Erwin AL, Desnick RJ

    Molecular genetics and metabolism 2019; (128(3)):288-297 doi:10.1016/j.ymgme.2018.12.008.

    PMID: 30685241
  18. 18

    Porphyria cutanea tarda: a unique iron-related disorder.

    Leaf RK, Dickey AK

    Hematology. American Society of Hematology. Education Program 2024; (2024(1)):450-456 doi:10.1182/hematology.2024000664.

    PMID: 39644053
  19. 19

    Dermatologic Manifestations of Chronic Hepatitis C Infection.

    Sayiner M, Golabi P, Farhat F, Younossi ZM

    Clinics in liver disease 2017; (21(3)):555-564 doi:10.1016/j.cld.2017.03.010.

    PMID: 28689593
  20. 20

    Hepatic porphyria: A narrative review.

    Arora S, Young S, Kodali S, Singal AK

    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2016; (35(6)):405-418 doi:10.1007/s12664-016-0698-0.

    PMID: 27796941
  21. 21

    A Rare Case of Hereditary Hemochromatosis Presenting With Porphyria Cutanea Tarda.

    Varada N, Tun KM, Chang MJ, et al.

    Cureus 2023; (15(7)):e41299 doi:10.7759/cureus.41299.

    PMID: 37539416

This page provides general information on managing porphyria triggers for educational purposes only. Always consult your porphyria specialist or hematologist before changing your diet, starting new medications, or managing an acute attack.

Get notified when new evidence is published on Porphyria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.